研究单位：[1]Lepu Medical Technology (Beijing) Co., Ltd.[2]Xuanwu Hospital Capital Medical University,Beijing,Beijing,China,100053[3]The First Affiliated Hospital of Fujian Medical University,Fuzhou,Fujian,China,350004[4]ZhuJiang Hospital of Southern Medical University,Guangzhou,Guangdong,China,510260[5]Renmin Hospital of Wuhan University,Wuhan,Hubei,China,430060[6]The Second Affiliated Hospital of Air Force Medical University,Xi'an,Shaanxi,China,524001[7]West China Hospital of Sichuan University,Chengdu,Sichuan,China,610044[8]The Second Affiliated Hospital Zhejiang University School of Medicine,Hangzhou,Zhejiang,China,310003
The purpose of this clinical trial is to verify the efficacy and safety of rechargeable implantable deep brain stimulation (DBS) system for the treatment of advanced primary Parkinson's disease.
